Ebola vaccine (ChAd3-EBO-Z) clinical trial shows it well tolerated and stimulates strong immune response
by Staff from Outbreak News Today on (#VAJ0)
A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the US, according to a study published this week in ["]
